Condition (MeSH)
Truncus Arteriosus, Persistent
ClinicalTrials.gov lists 14 trials for Truncus Arteriosus, Persistent or a narrower condition beneath it. Genoss Co., Ltd. has the most among industry and government lead sponsors, with 3.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
14 of the 14 trials are tagged with Truncus Arteriosus, Persistent itself; the rest are tagged with a narrower condition beneath it.
When did Truncus Arteriosus, Persistent trials start? (11)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 3 |
| 2023 | 2 |
| 2022 | 1 |
| 2021 | 1 |
| 2017 | 1 |
| 2016 | 1 |
| 2015 | 1 |
| 2008 | 1 |
| 2007 | 1 |
Showing 10 of 11 earlier years.
No forecast is made for this condition: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Truncus Arteriosus, Persistent trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 8 |
| Observational | 6 |
How many Truncus Arteriosus, Persistent trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 6 |
| Enrolling by invitation | 2 |
| Completed | 4 |
| Terminated | 1 |
| Withdrawn | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Truncus Arteriosus, Persistent trials? (5)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Genoss Co., Ltd. | 3 |
| C. R. Bard | 1 |
| Edwards Lifesciences | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| PECA Labs | 1 |
Which serious adverse events do Truncus Arteriosus, Persistent trials report? (4)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Cardiopulmonary insufficiency requiring ECMO | 4 | 1 |
| Cardiac arrest requiring CPR and medications | 3 | 1 |
| Seizures | 3 | 1 |
| Need for dialysis | 2 | 1 |
Which publications cover Truncus Arteriosus, Persistent? (6)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Novel pathogenic GATA6 variant associated with congenital heart disease, diabetes mellitus and necrotizing enterocolitis. | Pediatric research | 2024 | Yes |
| Echocardiographic evaluation of coronary arteries in congenital heart disease. | Cardiology in the young | 2015 | Yes |
| Long-term results of right ventricular outflow tract reconstruction in neonatal cardiac surgery: options and outcomes. | The Journal of thoracic and cardiovascular surgery | 2009 | Yes |
| [Prenatal diagnosis of truncus arteriosus communis (type I) in diabetic pregnancy]. | Zentralblatt fur Gynakologie | 1992 | Yes |
| Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. | Teratology | 1990 | Yes |
Showing 5 of 6 publications.
Prevalence (48)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Common arterial trunk | Prevalence at birth | 1-9 / 100 000 | United Kingdom | GB | Exact |
| Common arterial trunk | Prevalence at birth | 1-9 / 100 000 | United Kingdom | GB | Exact |
| Common arterial trunk | Prevalence at birth | 1-9 / 100 000 | United Kingdom | GB | Unspecified |
| Common arterial trunk | Prevalence at birth | 1-5 / 10 000 | Switzerland | Not stated | Exact |
| Common arterial trunk | Point prevalence | Unknown | Worldwide | Not stated | Exact |
Showing 5 of 48 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Common arterial trunk | 3384 | Exact | Orphadata Science knowledge files, Product 1 |
| Common arterial trunk | 3384 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: drugs tested and sub-conditions in mesh.